Gilead Sciences (GILD) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased compared with the immediately preceding quarter and also rose from the same quarter one year earlier. The company reported higher total revenue in the current period.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased compared with the immediately preceding quarter and also rose from the same quarter one year earlier. The company reported higher total revenue in the current period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$6.6B
Revenue reported for this quarter.
Quarter-over-quarter
+3.9%
Change from the immediately preceding quarter.
Year-over-year
+5.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$27.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $7B | -5.1% |
| Dec 31, 2022 | $7.4B | +2.0% |
| Mar 31, 2023 | $6.4B | -3.6% |
| Jun 30, 2023 | $6.6B | +5.4% |
Revenue performance
Revenue growth was evident both quarter over quarter and year over year.
Quarterly comparison
Compared to the prior quarter, revenue increased sequentially, reversing the decline seen in the preceding period. Against the same quarter a year ago, revenue also showed an increase.
What to watch
Given the variability in quarterly revenue trends, future performance will be important to monitor.